Category Archives: Cancer

Mikhail Blagoskylonny Reveals the Amazing Healing Properties of Rapamycin

The former New York oncology professor of Roswell Park Cancer Institute has gained popularity in the world of his incredible works in health research issues. He has conducted numerous researches on cancer therapies. Through his incredible and tremendous passion for cancer research, Mikhail Blagoskylonny was appointed as the chief editor of Oncortarget, an international peer- review journal that has published several cancer journals. This has earned him great experiences allowing him to publish aging-related information.

The Benefits of Rapamycin

Mikhail Blagoskylonny is renowned for promoting Rapamycin, a cancer drug to increase human being’s lifespan. The drug has multiple benefits in treating an array of diseases. For instance, Rapamycin is known to treat Lymphangioleiomyomatosis, reduce kidney toxicity through its immunosuppressant properties, and treat hemolytic uremic syndromes and cancer.Moreover, Rapamycin has proven positive results in curing Tuberculosis Sclerosis Complex, facial angiofibromas, Muscular Dystrophy as well as treating Alzheimer’s disease. Today, Rapamycin can be found in pharmacy market as Rapamune, and some people name it as Sirolimus. However, some extensive researches are in process to determine certain treatment processes. Today most people are happy about Mikhail discovery of Rapamycin, which has ensured the repair of cells and decreased the damage of cells.

Mikhail Blagoskylonny’s Profile and Research Activities

Besides this, Mikhail, also known as Misha is the author of more than 270 research book chapters, articles and reviews. He is the editor of cancer therapy, the American Pathology Journal, Cell Death and Differentiation, International Journal of Cancer and Autophagy. As such, he has cemented not only broad interests in cellular biology but also in molecular biology to clinical studies. This includes cellular sentences, signal transduction, cell cycle and anticancer therapeutics emphasizing on the basic science translation into new anticancer approaches. As such, institutes like Roswell Park pride themselves for recruiting Mikhail Blagoskylonny.Before he was appointed to be the professor of Oncology at the Roswell Park Cancer Institute in 2009, Mikhail was selected to be the Associate Medicine professor at the College of New York that is located at Valhalla. He has also served the Ordway Research Institute of Albany in New York as a senior scientist. Additionally, his educational background has played a significant role in supporting him in his works. For example, Mikhail is a former student of St, Petersburg’s First Pavlov State Medical University. He possesses an internal Medicine M.D and an Experimental Medicine and Cardiology Ph.D. from the same University.

Oncotarget and its Corresponding Fields of Research

Oncotarget is an open access medical journal that covers different aspects of oncology. It was first published in the year 2010 by the Impact Journals. It’s function is to publish papers online at a fee. Oncotarget’s mission is to come up with scientific results that are readily available. This is attained through intensive research to give room for further discovery. It is linked through their networks to different fields of study. Under the leadership of highly trained scientists, the journals aid researchers in contribution and the progress of science. The success of Oncotarget has led to the formation of sections beyond the field of oncology. Below are examples of further sections beyond oncology:

#1 Section on Pathology

Pathology section in Oncotarget was launched under the leadership of Michael Blagosklonny; who was the former Editor in Chief of American Journal of Pathology (AJP). The increasingly growing Oncotarget led to the formation of Pathology. There are several advantages of pathology section on Oncotarget as compared to ordinary pathology journals as shown below:

  • It has higher impact factor
  • Has relatively higher rapid publication
  • It is possible to submit papers rejected by other journal review platforms. Normally, it takes 1-5 days for the papers to be crosschecked.

#2 Sections on Aging (Gerotarget)

The section’s mandate is to publish high-end papers in different fields of researches related to; cellular senescence, pharmacological, signal transduction pathways, and genetics. The research also incorporates pathology model organisms in the treatment of age related diseases such as metabolic syndrome, hypertension, among others.

#3 Immunology and Microbiology Section

Success of Oncotarget has prompted the discovery of yet another section. The Immunology and Microbiology section deals in the publishing of papers in all areas in Oncotarget. Its specialty is research of cancer unrelated fields. Whereby, it incorporates the research of immunity cell development, antigen recognition, transplantation, clinical immunology, and mucosal immunology. Its submission is centralized via the Oncotarget systems. There are several advantages of this section as shown below:

  • Higher impact factor
  • Has relatively higher rapid publication
  • It is possible to communicate papers by the members of the Section Editorial Advisory Board